CSF biomarkers in primary tauopathies
 


   Note: An Official Proposal has not been Submitted to NACC.


   Lead Investigator:    Chihiro Sato
   Institution      :    Washington University School of Medicine
   E-Mail           :    satochihiro@wustl.edu
   Proposal ID      :    1814



   Proposal Description:
   We are looking for 500uL-1mL ceretrospinal fluid (CSF) from neuropathologically confirmed cases of CBD, PSP, FTLD-MAPT (and for control, PiD, AGD, FTLD-TDP, normal control, AD, other neurodegenerative diseases) to further test and validate newly discovered biomarkers for CBD and FTLD-MAPT (MTBR-tau. Horie et al., Nat Med 2022). Total approximately N=20 from each disease group would be ideal and we truly appreciate coordination from your center. Many thanks.